Centre Léon Bérard at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Centre Léon Bérard takes part in 12 sessions at ESMO 2026 in Madrid. Its program centres on sarcoma, including gynaecological sarcomas, desmoid tumours and trastuzumab deruxtecan in desmoplastic small round cell tumours. Other sessions cover antibody-drug conjugates in ovarian and endometrial cancer, first-line immunotherapy in advanced non-small cell lung cancer, vulvar cancer and global cancer control.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Comprehensive cancer centre in Lyon, France, part of the Unicancer network of French cancer centres.
Chair
Fri Oct 23
16:15–17:45
Beyond traditional therapy: The impact of emerging approaches on sarcoma treatment
with University College London Hospitals
Sarcoma, CNS, head & neck and rare cancers
Chair
Sat Oct 24
10:15–11:45
ESMO-WHO-IARC collaboration in global cancer control
with International Agency for Research on Cancer (IARC)
Talk
Sat Oct 24
11:05–11:20
Systemic therapies: From localised to metastatic disease
Multidisciplinary insights for effective care in gynaecological sarcomas
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
13:15–13:20
Audience polling
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care · with Hospital Universitario Puerta de Hierro Majadahonda, University of California San Diego
Gynaecological cancers
Satellite
Sat Oct 24
13:55–14:10
Spotlight on PROC: An In-Depth Exploration of ADCs in Development
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care
Gynaecological cancers
Chair
Sun Oct 25
08:30–09:15
Locally advanced vulvar cancer
Gynaecological cancers
Chair
Sun Oct 25
08:30–10:00
Rapid oral 2: NSCLC, metastatic
with Hospital Universitario 12 de Octubre, Gustave Roussy
Lung & thoracic cancers
Abstract
Sun Oct 25
09:02–09:14
Invited Discussant 2661RO and 2617RO
Rapid oral 2: NSCLC, metastatic
Lung & thoracic cancers
Chair
Sun Oct 25
10:15–11:45
Proffered paper: Policy
with Netherlands Cancer Institute
Abstract
Sun Oct 25
10:35–10:45
Invited Discussant 3312O and 3313O
Proffered paper: Policy
Abstract
Mon Oct 26
09:07–09:12
Abstract
Mon Oct 26
09:24–09:29
Chair
Mon Oct 26
10:15–11:30
Optimal management of high-grade serous ovarian cancer with BRCA mutation
with LMU University Hospital Munich
Gynaecological cancers
Talk
Mon Oct 26
10:45–11:00
Drug interventions to reduce the risk of second primaries: Where do we stand?
Addressing the risk of second primary cancers
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Centre Léon Bérard

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction